MarketInOut Stock Screener Log In | Sign Up

Dermapharm Holding SE

VIE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 11/19/2026 15:30
Dermapharm Holding SE stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeVIE
Market Capitalization1,736.41 mln
Float1.36 mln
Earnings Date02/12/2027

EPS

2.77
Solid

P / E

12.08
Fair value

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.54
Likely reliable

Relative Strength

7 / 100
Severely lagging

Debt / Equity

2.18
Very high leverage

Business Description

Dermapharm Holding SE is a German pharmaceutical company founded in 1991 that produces and sells a wide range of established branded medicines, health supplements, cosmetics, and medical devices across Europe, the United States, and China. Its product portfolio covers areas such as skin care, heart health, pain relief, women's health, and allergy treatment, sold under well-known brand names including Dekristol, Tromcardin, and Herpotherm. The company also imports original branded pharmaceuticals from other manufacturers, distributing them through its axicorp brand. Dermapharm operates as part of the Themis Beteiligungs-AG group and is headquartered in Grünwald, Germany.

Key Fundamentals

EPS2.77
P/E12.08
ROE22.18
RPS22.36
ROIC10.49
ROA6.52
Interest Cover5.29
EBITDA, mln335
EV / EBITDA8.60
EV / EBIT12.04
Revenue, mln1,181
EV / Revenue2.44

Quote Details

Last 33.45
Change -1.6 (-4.56%)
Open 34.20
Volume 0
Turnover 0
Average Volume 0

Financial Ratios

Pre-Tax Profit Margin16
Current Ratio1.71
Price / Book3.43
Price / Free Cash Flow11.51
Debt / Equity2.18
Price / Sales1.66
PEG Ratio1.74

Financial Strength

Altman Z-Score1.95
Piotroski F-Score 7 / 9
Beneish M-Score-2.54
Price to Intrinsic Value0.86
Shiller PE Ratio17.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.95% 15 / 100   
1 Month -12.2% 14 / 100   
2 Months -15.64% 21 / 100   
6 Months -29.01% 12 / 100   
1 Year -2.79% 29 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog